SWEETY SAMUEL: Open Payments
NPI 1861128407 · VERONA, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,384 in 150 payments from 22 companies in 2025. Trend: 2023 $329 · 2024 $2,983 · 2025 $3,384
Food & beverage: $3,285Education: $99
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 10 | $351 |
| ABBVIE INC. | 25 | $320 |
| Arcutis Biotherapeutics, Inc. | 16 | $301 |
| Novartis Pharmaceuticals Corporation | 11 | $295 |
| Incyte Corporation | 11 | $273 |
| Galderma Laboratories, L.P. | 10 | $270 |
| PFIZER INC. | 10 | $246 |
| Lilly USA, LLC | 6 | $186 |
| LEO Pharma Inc. | 5 | $179 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 4 | $159 |
Products named: Bimzelx, DUPIXENT, Zoryve, OPZELURA, SKYRIZI, NEMLUVIO, LITFULO, EBGLYSS.
Industry payments across NJ — which companies pay providers there.
